does mhbp cover glp-1 If you're covered by the State Health Benefit Plan (SHBP) and take a weight-loss medication (like Wegovy or Zepbound), a change is coming. Starting February 1, 2026, SHBP will require these medications 7 things to know about

Complete tirzepatide dosage chart in units for 5mg/ml, 10mg/ml, 20mg/ml, and 40mg/ml concentrations

Some insurance plans require prior authorization before approval

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), approved for diabetes and obesity, have shown promise in modulating reward-related brain pathways, suggesting potential benefits in the management of AUD

Conclusions Our findings do not support an increased risk of intestinal obstruction in T2DM patients prescribed GLP-1 RAs compared to other anti-diabetic medications.

Learn what happens after GLP-1 weight loss, including maintenance planning, muscle preservation, weight regain risk, dose review, and long-term metabolic health.

FDA is requesting that the risk be removed from the warnings and precautions section of labeling for the GLP-1 obesity drugs Eli Lilly and Co.s Zepbound (tirzepatide) and Novo Nordisk A/S Saxenda (liraglutide) and Wegovy (semaglutide).